Akzo Nobel stock
AKZA.ASAMSAkzo Nobel N.V., Basic MaterialsISIN NL0013267909
63Score 63 out of 100, Neutral
Price and trend
77 / 100
Price history
+8.6% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 11% above it.
Since July 2026 the 50-day line has been above the 200-day line; the trend has turned up.
Overheated: the price has risen very quickly lately (RSI 77).
The price is 4.3% below its 52-week high. Largest decline in 20 years: 65% (July 2007 to November 2008).
Chart figures for advanced users
- SMA 50$65.35
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$63.29
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)77
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$52.41
- The lowest closing price of the last twelve months.
- Resistance$73.62
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Akzo Nobel N.V. belongs to the Chemicals (Specialty) industry (Netherlands) and, with a market value of $12.07B, is number 27 of 106 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $11.26B (down 5.2% year on year) and earnings of $703.64M (up 17.2%).
- For fiscal 2026, analysts expect on average revenue of $11.1B (down 1.3%) and adjusted earnings per share of $4.33 (up 8.4%).
Show more
- MEQIRI Score 63 out of 100 (Neutral): rank 154 of 461 in Basic Materials, median 57.
- Our model puts fair value at $73.71, with the price 4% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Share buybacksShare count down 11% since 2020.Capital allocation 69
- Consistently profitableProfit in all 10 fiscal years from 2016 to 2025.Fundamentals 73
- High dividend yieldDividend yield 3.12%, Chemicals (Specialty) median 1.97%.Capital allocation 69
Weaknesses
- High debtDebt 1.3 times equity (latest quarter), Chemicals (Specialty) median 0.63.Stability 63
Its standout strengths are momentum and technical analysis, while growth holds the score back.
Daily figure as of 13 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 64 to 63.
Fundamentals are strong, with stable profits.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk medium
How well MEQIRI warnsIn the middle among smaller stocks.
From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- cyclical sector (energy or materials), as a group, crashed more often in the backtest
Valuation
Valuation signal
Fairly valuedIn our model the price counts as cheap below $56.70 and expensive above $105.31 (uncertainty medium, based on the price swings of the past year).
Calculated with a cost of equity of 7.4%. At 8.4% the fair value would be $61.24, at 6.4% it would be $92.38.
Valuation metrics
From the cash-flow model alone; the profit includes one-off items, so there is no industry value.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue fell 5% on the twelve months before. Revenue has stayed largely stable since 2006.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 40%, operating 8%, net 6%.
Debt & balance sheet
latest quarterDebt is elevated. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 10 Feb 2027in 89 days
- Last reported
- 21 Oct 2026EPS reported $1.12 (expected $1.26)below expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- $4.33−0.9%
- Revenue
- $11.1B−0.2%
- Earnings per share
- $4.72−1.3%
- Revenue
- $11.33B−0.6%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook confirmed
Share price after the results: −1.5%Full year guidance is unchanged with no change in assumptions, and third quarter adjusted EBITDA of around EUR 390 million with broadly flat volumes is expected.
“For Q3, we expect adjusted EBITDA of around EUR 390 million. Volumes are forecast to be broadly flat.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 22 Jul 2026 (fiscal Q2 2026), read by AI.
What happened at Akzo Nobel
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
461 rated companies in Basic Materials
- This company
- 63
- Sector median
- 57
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals (Specialty)
The next larger and next smaller companies by market value
- Covestro1COV.DE $13.9B43
- Formosa Plastics1301.TW $13.24B41
- RPM InternationalRPM $13.15B67
- Swancor Advanced Materials688585.SS $12.88B49
- Satellite Chemical002648.SZ $11.72B71
- AlbemarleALB $11.19B51
- Grace Fabric Technology603256.SS $10.99B62
- Evonik IndustriesEVK.DE $10.84B61
ETFs that hold Akzo Nobel
Held by 123 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| iShares STOXX Europe 600 Chemicals UCITS ETF (DE)EXV7 | 4.53% | 0.46% | €114.82M |
| Xtrackers MSCI Europe Materials Screened UCITS ETF 1CDXSC | 1.45% | 0.17% | €67.38M |
| State Street SPDR MSCI Europe Materials UCITS ETFSPYP | 1.42% | 0.18% | €110.91M |
Show 5 more
| iShares EURO STOXX Mid UCITS ETFIQQM | 1.30% | 0.40% | €560.15M |
| iShares MSCI EMU Mid Cap UCITS ETF EURIS3H | 0.83% | 0.49% | €570.32M |
| L&G MSCI Europe Climate Pathway UCITS ETFDELF | 0.66% | 0.10% | €1.42B |
| iShares STOXX Europe Mid 200 UCITS ETF (DE)EXSD | 0.64% | 0.20% | €634.13M |
| UBS MSCI EMU Socially Responsible UCITS ETF A DistributionUIMR | 0.64% | 0.20% | €1.23B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 1 May 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.